Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001554
Abstract: Objective To investigate the factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma (PTMC). Methods We divided 99 patients with PTMC who underwent total thyroidectomy… read more here.
Keywords: remnant ablative; ablative therapy; therapy; initial 131i ... See more keywords
TSH ≥30 mU/l may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
Sign Up to like & getrecommendations! Published in 2023 at "European thyroid journal"
DOI: 10.1530/etj-22-0219
Abstract: BACKGROUND Purpose To determine whether thyroid stimulating hormone level ≥30 mU/l is necessary for radioiodine (131I) remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC), as well as its influencing factors and predictors. METHODS… read more here.
Keywords: patients differentiated; differentiated thyroid; rra; remnant ablation ... See more keywords